THE PATTERNS OF FUNDUS ABNORMALITIES AND CARDIOVASCULAR DISEASES

Purpose: The patterns of findings in a fundus in cardiovascular (СVD) and chronic non-communicable diseases have been investigated in European and North American populations with heterogeneous results. The subject has not been practically studied in Russian population. We performed systematic literature search for 15 years (2001-2015) to summarize the data from published studies on the relationship between fundus abnormalities and CVD and its’ complications. Methods. We used the Internet resources: PubMed (http://www.ncbi.nlm.nih.gov/pubmed/), Scopus (http://www.scopus.com), e-library (http://elibrary.ru/defaultx.asp) and major domestic cardiological, therapeutic and ophthalmologic journals. Results. The analysis of the data accumulated in the literature showed the associations between specific patterns of fundus abnormalities and CVD, and also a prognostic impact of these changes on the development of complications of CVD. Namely are shown: the association between a narrowing of arteries and dilation of veins and the risk of ischemic heart disease and fatal CVD; the association between an increase of vein diameter and the risk of a cerebral stroke; the relationship between fundus changes and aging and risk factors of CVD; the contribution of ophthalmoscopic identification of fundus abnormalities to the stratification of cardiovascular risk.

fundus, arteries and veins of fundus, retina, population, CVD, atherosclerosis, coronary artery diseases, stroke, fundus and ageing, retinal arteriopathy, ophthalmoscopy

1. Венедиктов Д.Д. К разработке концепции развития (реформирования, модернизации) здравоохранения // Здравоохранение. 2008. № 10. С. 117-129.

2. Шабалин В.Н. Основные закономерности старения организма человека // Здравоохранение Российской Федерации. 2009. № 2. С. 13-18.

3. Takayama M., Hirose N., Arai Y. et al. Morbidity of TokyoArea Centenarians and Its Relationship to Functional Status. Relationship to Functional Status // J. Gerontol. A. Biol. Sci. Med. Sci. 2007. Vol. 62, N 7. P. 82-774.

4. Hadley E.C., Rossi W.K. Exceptional survival in human populations: National Institute on Aging perspectives and programs // Mech. Ageing Develop. 2005. Vol. 126. P. 4-231.

5. Grunwald J.E., Alexander J., Maguire M. et al. The CRIC Study Group Prevalence of Ocular Fundus Pathology in Subjects with Chronic Kidney Disease // Am. J. Cardiol. 2010. Vol. 5. P. 867-873.

6. SanjibSaha, Ulf-G Gerdtham and Pia Johansson Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases // J. Environ. Res. Public. Health. 2010. Vol. 7. P. 567-587.

7. Задионченко В.С., Адашева Т.В., Шамшинова А.М. Глаз - зеркало сердечно-сосудистой патологии. Эволюция представлений о гипертонической ретинопатии // РФК. 2010. № 6. С. 853-858.

8. Классификация изменений картины глазного дна при артериальной гипертензии / Н.Б. Шульпина и др. // Терапевт. офтальмология. М., 1985. С. 476-510.

9. Киселева Т.Н., Ежов М.В., Аджемян Н.А. Нарушение ретинальной циркуляции при артериальной гипертензии // Фарматека. 2014. № 20. С. 14-18.

10. Классификации гипертонической ретинопатии / Л.А. Канцельсон и др. // Сосудистые заболевания глаза. М., 1990. 272 c.

11. Wang J.J., Liew G., Wong T.Y. et al. Cardiovascular medicine Retinal vascular calibre and the risk of coronary heart disease-related death // J. Heart. 2006. Vol. 92. P. 1583-1587.

12. Grunwald J.E., Alexander J., Maguire M. et al. The CRIC Study Group Prevalence of Ocular Fundus Pathology in Subjects with Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study // Clin. J. Am. Soc. Nephrol. 2010. Vol. 5. P. 867-873.

13. Juan E. Grunwald, Gui-Shuang Ying et al. Association Between Retinopathy and Cardiovascular Disease in Patients with Chronic Kidney Disease (From the Chronic Renal Insufficiency Cohort [CRIC] Study // Am. J. Cardiol. 2012. Vol. 110. P. 246-253.

14. Daien V., Carriere I., Kawasaki R. et al. Retinal Vascular Caliber is Associated with Cardiovascular Biomarkers of Oxidative Stress and Inflammation: The POLA Study // PLoS One. 2013. Vol. 8. P. 1089-1371.

15. Десять ведущих причин смерти в мире // Информ. бюл. 2014. № 310. С. 1-2

16. Ogagarue R., Lutsey P.L., Klein R. et al. Association of Ideal Cardiovascular Health Metrics and Retinal Microvascular Findings: The Atherosclerosis Risk in Communities Study // J. Am. Heart Assoc. 2013. Vol. 2. P. 92-97.

17. Klein R., Myers C.E., Knudtson M.D. et al. The Relationship of Blood Pressure and Other Factors to Serial Retinal Arteriolar Diameter Measurements Over Time: the Beaver Dam Eye Study MPH // Arch. Ophthalmol. 2012. Vol. 130. P. 1019-1027.

18. Ryo Kawasaki, Jing Xie, Ning Cheung et al. Retinal Microvascular Signs and Risk of Stroke: The Multi-Ethnic Study of Atherosclerosis (MESA) // Stroke. 2012. Vol. 43. P. 3245-3251.

19. McGeechan K., Liew G., Macaskill P. et al. Meta-analysis: retinal vessel caliber and risk for coronary heart disease // Ann. Intern. Med. 2009. Vol. 151. P. 404-413.

20. Wang J.J., Liew G., Klein R. et al. Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations // Eur. Heart J. 2009. Vol. 28. P. 1984-1992.

21. McGeechan K., Liew G., Macaskill P. et al. Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis // Am. J. Epidemiol. 2009. Vol. 170. P. 1323-1332.

22. Wong T.Y., Klein R., Sharrett A.R. et al. Retinal arteriolar diameters and risk for hypertension // Ann. Intern. Med. 2004. Vol. 140. P. 55-248.

23. Wong T.Y., Hubbard L.D., Klein R. et al. Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br. // J. Ophthalmol. 2002. Vol. 86. P. 1007-1013.

24. Чазова И.Е., Ратова Л.Г., Бойцов С.А. и др. Диагностика и лечение артериальной гипертонии // Системные гипертензии. 2010. № 3. С. 20-56.

25. Psaty B., Smith N., Siscovick D. et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis // JAMA. 1997. Vol. 277. P. 739-745.

26. Lindholm L.H., Carlberg B., Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis // Lancet. 2005. Vol. 366. P. 1545-1553.

27. Mancia G., de Backer G., Dominiczak A. et al. Guidelines for the management of arterial hypertension. Guidelines Committee 2007. European Society of Hypertension / European Society of Cardiology // J. Hypertens. 2007. Vol. 25. P. 1105-1187.

28. Задионченко В.С., Шамшинова А.М., Адашева Т.В., Аракелян М.А. Является ли глаз органом-мишенью при артериальной гипертонии? // Системные гипертензии. 2008. № 4. С. 47-48.

29. Зуева М.В. Функциональные аспекты естественного и патологического старения головного мозга у долгожителей и перспективы исследований зрительной системы // Рос. офтальмологич. журн. 2015. № 4. С. 60-70.